Visit Biological Dynamics at Booth 10071.
Attend the 2024 ASCO Annual Meeting and be part of the most significant gathering of oncology professionals worldwide, making connections and forging collaborations that can change the landscape of cancer care.
Visit Biological Dynamics at Booth 4340.
The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world
US HUPO 2024 features a full program of outstanding plenary speakers, a great variety of 14 parallel scientific sessions and oral presentations, as well as educational short courses and topic-specific evening workshops. Our oral presentation sessions cover diverse and fascinating proteomic topics, such as Enabling Pandemic Proteomics, Automation and Large-Scale Proteomics, Microbiome Multi-omics and Proteomics to Advance Equity.
Leveraging next gen technologies beyond conventional biomarker drug discovery!
MarketsandMarkets bring to you the 9th Annual Biomarker and CDx Conference - West Coast Edition scheduled to be held on 8th - 9th February 2024 in San Diego, USA. This event will have an introduction to turning biomarkers into companion diagnostics.
The Precision Medicine World Conference (PMWC) is an independent and established conference series considered to be the preeminent precision medicine conference that attracts recognized leaders, top global researchers and medical professionals, and innovators across healthcare and biotechnology sectors to showcase practical content that helps close the knowledge gap between different sectors, thereby catalyzing cross-functional fertilization and collaboration.
Biological Dynamics’ Senior Scientist, Jean Lewis, PhD will be presenting her work on using our technology to screen whole blood and plasma samples from pancreatic cancer patients for the presence of exosomes and exo-proteins.
Biological Dynamics will present a talk, "A Novel Technology to Isolate Nanoparticles and Macromolecules from Complex Biological Fluids", from 11:05 am to 11:25 am on Friday, November 10th at the AACC Emerging Clinical & Laboratory Diagnostics in Healthcare Ecosystem conference.
Biological Dynamics will attend the ASCO Annual Meeting June 2 – 6, 2017 in Chicago, IL. This meeting, which is attended by 30,000 oncology professionals from around the world, will provide education sessions presented by world-renowned leaders in the field of oncology. Sessions will focus on state-of-the-art treatment modalities, new therapies, and ongoing controversies.
Join us at Next Generation Dx Summit 2016!
Biological Dynamics' CEO, Raj Krishnan will be sharing his perspectives on validating clinical utility of cancer diagnostic solutions in Clinical Utility and Cost Effectiveness of Predictive Cancer Biomarkers panel discussion at 3:35 PM on Friday, August 26.
BIO returns to San Franscisco and so is Biological Dynamics!
Please join us at 7AM at the conference site, as Biological Dynamics CEO presents the latest company developments at Molecular Med Tri-Con 2016.
At the symposium renowned speakers from the fields of science and business will investigate topics, such as biomarkers, biobanking, sample archival, personalized medicine and monitoring from a holistic perspective. Mark Adler, MD, Chairman of SAB, will present clinical perspectives on treatment response monitoring using Biological Dynamics technology.
On Thursday, Aug 20, 12:35 PM, Biological Dynamics CEO, Raj Krishnan, is presenting "Quantification of Circulating Biomarkers from Plasma and Serum Using AC Electrokinetics."
Biological Dynamics CEO, Raj Krishnan, participates in the "Diagnostic Tools – New Advances and Latest Developments in Technology" panel 1:45PM-2:30PM.
Biological Dynamics team attends Annual ASCO 2015 Meeting in Chicago, IL. The Annual Meeting brings together 30,000 oncology professionals from around the world. Education sessions feature world-renowned faculty discussing state-of-the-art treatment modalities, new therapies, and ongoing controversies in the field.
On Thursday, April 16 at 10:05PM, Biological Dynamics President and CTO, David Charlot, is presenting "Quantification of Circulating Biomarkers from Plasma and Serum Using AC Electrokinetics"
Biological Dynamics presents at 8:45 AM at this annual investor and partnering conference conference, joined by investors and biopharma executives from around the world.
Biological Dynamics is a private molecular diagnostics company located in San Diego. Our proprietary technology offers a novel, fast, and cost-effective lab-on-chip ACE platform that isolates nanoparticles from high conductance physiological solutions.
Our product, the TR(ACE)™ assay, will utilize the platform for monitoring treatment response in oncology. TR(ACE)™ has not been cleared or approved by the U.S. FDA or any foreign regulatory agency.
